M. De Bruin

First name
M.
Middle name
L.
Last name
De Bruin
Peeters, P. J., Bazelier, M. T., Leufkens, H. G., Auvinen, A., van Staa, T. P., de Vries, F., & De Bruin, M. L. (2016). Insulin glargine use and breast cancer risk: Associations with cumulative exposure. Acta Oncol. http://doi.org/10.3109/0284186x.2016.1155736
View
Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., et al. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825
View
Essers, I., Stolwijk, C., Boonen, A., De Bruin, M. L., Bazelier, M. T., de Vries, F., & van Tubergen, A. (2016). Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2014-206147
View
Grimaldi-Bensouda, L., Klungel, O., Kurz, X., de Groot, M. C., Afonso, A. S. M., De Bruin, M. L., et al. (2016). Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD). BMJ Open. http://doi.org/10.1136/bmjopen-2015-009147
View
Bronsveld, H. K., Peeters, P., de Groot, M. C. H., de Boer, A., Schmidt, M. K., & De Bruin, M. L. (2017). Trends in breast cancer incidence among women with type-2 diabetes in British general practice. Prim Care Diabetes. http://doi.org/10.1016/j.pcd.2017.02.001
View
Knapen, L. M., de Jong, R. G., Driessen, J. H., Keulemans, Y. C., van Erp, N. P., De Bruin, M. L., et al. (2017). Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12833
View
But, A., De Bruin, M. L., Bazelier, M. T., Hjellvik, V., Andersen, M., Auvinen, A., et al. (2017). Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study. Diabetologia. http://doi.org/10.1007/s00125-017-4312-5
View
de Jong, R., Peeters, P., Burden, A. M., De Bruin, M. L., Haak, H. R., Masclee, A. A. M., et al. (2018). Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK. Cancer Epidemiol. http://doi.org/10.1016/j.canep.2018.04.008
View
Ibanez, L., Sabate, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., et al. (2019). Incidence of Direct Oral Anticoagulant use in patients with non-valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-national drug utilization study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14071
View
Sabate, M., Vidal, X., Ballarin, E., Rottenkolber, M., Schmiedl, S., Grave, B., et al. (2021). Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015). Front Pharmacol. http://doi.org/10.3389/fphar.2021.682890
View